Nerve Pain, Neuralgia, Neuropathic Pain
Conditions
Brief summary
This prospective cohort and multi-site study aims to develop Taiwan version (ID Pain-T) based on the original versions of ID Pain and also DN4, and validate both ID Pain-T and DN4 applied in Taiwanese subjects at the clinical setting.
Interventions
OTHERID-Pain DN4 Questionnaire
This is a non-interventional questionnaire validation study
Sponsors
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Study design
Observational model
CASE_ONLY
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Subjects without headache pain over 30 days and at least 18 years old who will visit the clinic, inclusive of male and female. * Subjects who are able to complete the ID Pain-T Questionnaire.
Exclusion criteria
* Subjects who are illiterate or unable to complete questionnaire. * Subjects who are currently participating in another study or have participated in another pain study within one month of study entry. * Subjects with low back pain are unable to participate in this study; as the sciatica caused by the piriformis (exclusive of the other types of sciatic pain), lumbago, unclear identification in nerve injury (e.g. complex regional pain syndrome type I) or mixed origin (e.g. cancer pain).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Determine the optimal cut-off score of ID Pain-T Questionnaire for screening of neuropathic pain | end of study |
Secondary
| Measure | Time frame |
|---|---|
| Evaluate the predictive power of ID Pain-T Questionnaire for diagnosis of neuropathic pain | end of study |
| Develop and evaluate validity of a short form diagnostic tool based on DN4 structure | end of study |
Outcome results
None listed